Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

787 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00857766

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 24 locations
View Trial Details
Completed

Chronic Obstructive Pulmonary Disease Endpoints Study

NCT00358358

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Absecon, New Jersey, United States
  • GSK Investigational Site Charleston, South Carolina, United States
  • GSK Investigational Site Greenville, South Carolina, United States
  • GSK Investigational Site Spartanburg, South Carolina, United States
View Trial Details
Completed

Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations

NCT00115492

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +7 more
Locations
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 110 locations
View Trial Details
Completed

Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00268216

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
View all 459 locations
View Trial Details
Completed

BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic Bronchitis

NCT01958008

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Berlin, Germany
  • Boehringer Ingelheim Investigational Site Frankfurt, Germany
  • Boehringer Ingelheim Investigational Site Gauting, Germany
  • Boehringer Ingelheim Investigational Site Großhansdorf, Germany
View Trial Details
Completed

SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease

NCT00361959

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Grimmenstein, Austria
  • GSK Investigational Site Mödling, Austria
  • GSK Investigational Site Salzburg, Austria
  • GSK Investigational Site Vienna, Austria
View all 166 locations
View Trial Details

Related conditions